Follow-up of mycosis fungoides

Abstract

Mycosis fungoides (MF) is the most common form of primary cutaneous T-cell lymphoma with an indolent course. The tumor, node, distant metastasis, and blood (TNMB) staging system is still the best method for determining prognosis. Individualized, TNMB-compliant conservative treatment approach is the basis of MF patient management. Treatment responses should be evaluated according to standardized guidelines based on objective criteria. There is no consensus on the follow-up of patients with cutaneous lymphoma, and the frequency of follow-up should be planned individually for life, depending mainly on disease stage; primary cutaneous lymphoma subtype; and the treatment agent used.